Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Regeneron Therapeutics, Inc. (NASDAQ: REGN) from August 1, 2025 to May 15, ...
Newspoint on MSN
No CBSE class 10 board certificate if you fail the third language... new rule to be implemented starting this year
CBSE Three-Language Policy: The Central Board of Secondary Education (CBSE) has implemented a three-language policy starting ...
The institute invites applications for the inaugural Fall 2026 intake across various UG programmes, commencing this September ...
Vanda Pharma cash could be depleted by the end of 2027; multiple pipeline bets heighten both risk and opportunity. Read my ...
In this week's Tour Report, the reason why Collin Morikawa tested irons off a cart path to get ready for the Open ...
Strong Buy on oncology pipeline gains and LIPFENDRA launch, with KEYTRUDA patent risks. Click for this MRK update.
Armed with grit and determination, these would-be business owners scrape together financing on a deal-by-deal basis to buy up ...
Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven disorders Concurrent $132 million private investment w ...
Should the New York Jets jump on the opportunity to make a blockbuster move for Texans quarterback C.J. Stroud?
New! Sign up for our free email newsletter.
U.S. 3 Year Treasury Note 0.016 4.180% U.S. 5 Year Treasury Note 0.045 4.248% U.S. 7 Year Treasury Note 0.060 4.375% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results